Skip to content

Swiss Neonatal Network & Follow-up Group

Swiss Neonatal Network & Follow-up Group

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04239508
Acronym
SwissNeoNet
Enrollment
1000
Registered
2020-01-27
Start date
2000-01-01
Completion date
2050-12-31
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asphyxia Neonatorum, Very Low Birth Weight Infant, Very Preterm Maturity of Infant

Brief summary

The chief aim of the Swiss Neonatal Network & Follow-Up Group (SwissNeoNet) is to maintain and / or improve the quality and safety of medical care for high-risk newborn infants and their families in Switzerland through a coordinated program of research, education and collaborative audit. In support of its aim, SwissNeoNet hosts the official medical quality register for the Swiss level III and level IIB units. Participation for these units is mandatory according to the intercantonal declaration for Highly Specialized Medicine (HSM) of September 22, 2011 and the Society's Standards for Levels of Neonatal Care in Switzerland.

Detailed description

Inaugurated in 1995, SwissNeoNet now routinely collects data from 9 level III, 10 level IIB and 14 neuro-/developmental pediatric units encompassing information about the care and outcomes of high-risk newborn infants. Data collection is monitored for population coverage, dataset completeness, plausibility and reliability. Data quality is audited within a three year cycle. Quality improvement SwissNeoNet releases an annual quality report for participating centers encompassing up to 20 process- and outcome quality indicators. It annually collects data on unit infrastructure evaluated by the Committee for the Accreditation of Neonatology Units (CANU). To discuss quality issues and educational purposes, it hosts bi-annual meetings/symposia for the NEO Directors Group and the Follow-up Group, respectively. The SwissNeoNet member platform offers tools for unit-to-unit quality improvement collaboration (mailing lists, event-organizer, forum, file-sharing and survey builder). Research SwissNeoNet coordinates cross-sectional and longitudinal cohort studies that are performed by local researchers using SwissNeoNet's prospectively collected data. These studies focus on mortality, morbidity and/or long-term outcome issues and the analysis of risk factors for development. The network disseminates its research in scientific articles in peer reviewed medical journals. Support SwissNeoNet supports the units logistically to ensure that each patient receives primary care (NICU bed availability) and follow-up assessments at 9 to 12 months corrected, 18 to 24 months corrected, and at 5.5 to 6 years of age (FU missing lists) to ensure early diagnosis and intervention. With regards to its Follow-up program, the SwissNeoNet also supports training of new staff and coordinates the launch of new testing instruments between centers.

Interventions

None listed

Sponsors

Department of Neonatology, Children's Clinic, Cantonal Hospital Aarau, Switzerland
CollaboratorUNKNOWN
Department of Neuropaediatrics, Children's Clinic, Cantonal Hospital Aarau, Switzerland
CollaboratorUNKNOWN
Department of Neonatology, University of Basel Children's Hospital (UKBB), Switzerland
CollaboratorUNKNOWN
Department of Neuropaediatrics and Developmental Medicine, University of Basel Children's Hospital (UKBB), Switzerland
CollaboratorUNKNOWN
Department of Pediatrics, San Giovanni Hospital Bellinzona, Switzerland
CollaboratorUNKNOWN
Department of Neonatology, University Hospital Berne, Switzerland
CollaboratorUNKNOWN
Department of Neuropaediatrics, University Hospital Berne, Switzerland
CollaboratorUNKNOWN
Development and Pediatric Neurorehabilitation Center, Biel, Switzerland
CollaboratorUNKNOWN
Department of Neonatology, Children's Hospital Chur, Switzerland
CollaboratorUNKNOWN
Department of Neuropaediatrics, Children's Hospital Chur, Switzerland
CollaboratorUNKNOWN
Department of Neuropediatrics, Cantonal Hospital Fribourg, Switzerland
CollaboratorUNKNOWN
University of Lausanne Hospitals
CollaboratorOTHER
Department of Neonatology, University Hospital Geneva (HUG), Switzerland
CollaboratorUNKNOWN
Division of Development and Growth, University Hospital Geneva (HUG), Switzerland
CollaboratorUNKNOWN
Neonatal and Paediatric Intensive Care Unit, Children's Hospital of Lucerne, Switzerland
CollaboratorUNKNOWN
Department of Pediatrics, Cantonal Hospital Muensterlingen, Switzerland
CollaboratorUNKNOWN
Department of Pediatrics, Cantonal Hospital Neuchatel, Switzerland
CollaboratorUNKNOWN
Cantonal Hospital of St. Gallen
CollaboratorOTHER
Department of Child Development, Children's Hospital St. Gallen, Switzerland
CollaboratorUNKNOWN
Department of Neonatology, Cantonal Hospital Winterthur, Switzerland
CollaboratorUNKNOWN
Social Pediatrics Center, Cantonal Hospital Winterthur, Switzerland
CollaboratorUNKNOWN
University Hospital, Zürich
CollaboratorOTHER
University Children's Hospital, Zurich
CollaboratorOTHER
Swiss Neonatal Network
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

of Minimal Neonatal Dataset (MNDS): All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight Inclusion criteria of Below 34 data collection, (B34): All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight Inclusion criteria of Swiss Asphyxia and Cooling Registry, (ASP): Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia

Design outcomes

Primary

MeasureTime frameDescription
Mortality0 to 6 yearsMortality in delivery room, during primary hospitalization or within first 6 years of life
Major morbidities of newborns0 to 6 yearsPeriod prevalences (i.e. incident proportions per year or period of years) of intraventricular hemorrhages, necrotizing enterocolitis, sepsis, retinopathy of prematurity, bronchopulmonary displasia, neurodevelopmental impairment at 2 or 6 years, and other

Countries

Switzerland

Contacts

Primary ContactMark Adams, PhD
mark.adams@usz.ch+41432533034
Backup ContactDirk Bassler, MD, MSc
dirk.bassler@usz.ch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026